Issues like stigma, low socio-economic status and lack of education are significant barriers in early screening, diagnosis and treatment. And these delays perpetuate the transmission cycle.

Tuberculosis patients who swallow their anti-TB pills under the watchful gaze of health care workers fare just as well as patients trusted to self-medicate, according to a new meta-analysis.

Despite recent advances in TB diagnostics, current technologies suffer serious disadvantages.

A group of activists launched the Global Coalition of TB Activists (GCTA), a new network that aims to put communities affected by tuberculosis at the centre of decision making in the fight against TB.

World TB Day is an opportunity to raise awareness about the burden of tuberculosis worldwide and the status of TB prevention and control efforts. It is also an opportunity to mobilize political and social commitment for further progress.

HIV and TB co-infection makes up one-third of all TB-related deaths worldwide. TB is a growing threat to people who use drugs, particularly when set against the backdrop of high vulnerability to, and prevalence of, HIV.

EMA's response to TB CAB letter regarding the filing of the drugs delamanid and bedaquiline for market approval.

The new FY 2011/12 Report to Congress on TB highlights key programmatic achievements and collaboration of the different U.S. Government agencies involved in global TB programs, bringing comparative expertise to address the many challenges of TB.

The guide offers clear, practical advice on how to manage the patients who have multidrug-resistant tuberculosis.

1000 days to achieve international targets of 50% reductions in TB mortality and TB/HIV deaths by 2015